1. Home
  2. BYFC vs ADVM Comparison

BYFC vs ADVM Comparison

Compare BYFC & ADVM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BYFC
  • ADVM
  • Stock Information
  • Founded
  • BYFC 1946
  • ADVM 2006
  • Country
  • BYFC United States
  • ADVM United States
  • Employees
  • BYFC N/A
  • ADVM N/A
  • Industry
  • BYFC Savings Institutions
  • ADVM Biotechnology: Biological Products (No Diagnostic Substances)
  • Sector
  • BYFC Finance
  • ADVM Health Care
  • Exchange
  • BYFC Nasdaq
  • ADVM Nasdaq
  • Market Cap
  • BYFC 63.8M
  • ADVM 59.5M
  • IPO Year
  • BYFC 1996
  • ADVM 2014
  • Fundamental
  • Price
  • BYFC $6.30
  • ADVM $2.22
  • Analyst Decision
  • BYFC
  • ADVM Strong Buy
  • Analyst Count
  • BYFC 0
  • ADVM 5
  • Target Price
  • BYFC N/A
  • ADVM $26.40
  • AVG Volume (30 Days)
  • BYFC 5.5K
  • ADVM 430.7K
  • Earning Date
  • BYFC 07-29-2025
  • ADVM 05-14-2025
  • Dividend Yield
  • BYFC N/A
  • ADVM N/A
  • EPS Growth
  • BYFC N/A
  • ADVM N/A
  • EPS
  • BYFC N/A
  • ADVM N/A
  • Revenue
  • BYFC $32,732,999.00
  • ADVM $1,000,000.00
  • Revenue This Year
  • BYFC N/A
  • ADVM N/A
  • Revenue Next Year
  • BYFC N/A
  • ADVM $42.58
  • P/E Ratio
  • BYFC N/A
  • ADVM N/A
  • Revenue Growth
  • BYFC N/A
  • ADVM N/A
  • 52 Week Low
  • BYFC $4.68
  • ADVM $1.78
  • 52 Week High
  • BYFC $9.46
  • ADVM $10.14
  • Technical
  • Relative Strength Index (RSI)
  • BYFC 46.24
  • ADVM 36.90
  • Support Level
  • BYFC $6.11
  • ADVM $2.10
  • Resistance Level
  • BYFC $6.49
  • ADVM $2.33
  • Average True Range (ATR)
  • BYFC 0.17
  • ADVM 0.24
  • MACD
  • BYFC -0.01
  • ADVM 0.03
  • Stochastic Oscillator
  • BYFC 32.20
  • ADVM 32.65

About BYFC Broadway Financial Corporation

Broadway Financial Corp is active in the financial services domain. It is a savings and loan holding company in the United States. The Bank's business consists of deposits from the general public and using such deposits, together with borrowings and other funds, to make mortgage loans secured by residential properties and commercial real estate. Its deposits consist of passbook savings accounts, checking accounts, and negotiable order of withdrawal accounts, money market accounts and fixed-term certificates of deposit. The revenue is derived from interest income on loans and investments.

About ADVM Adverum Biotechnologies Inc.

Adverum Biotechnologies Inc is a clinical-stage company that aims to establish gene therapy as a new standard of care for prevalent ocular diseases. It develops gene therapy product candidates intended to provide durable efficacy by inducing sustained expression of a therapeutic protein. Its product candidate, ixoberogene soroparvovec (Ixo-vec), is a single, in-office intravitreal (IVT) injection gene therapy product designed to deliver long-term durable therapeutic levels of aflibercept associated with a robust, sustained treatment response, reducing the treatment burden and fluctuations in macular fluid associated with bolus anti-vascular endothelial growth factor (VEGF) IVT injections.

Share on Social Networks: